SAN DIEGO–(BUSINESS WIRE)–Aspera Biomedicines launches second ADAR1p150 crystallization experiment to the ISS aboard SpaceX CRS-34, advancing oral Rebecsinib for 20+ cancers.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
